Journal Scans
A Population-Based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States
Rate of Cytoreductive Nephrectomy for Metastatic RCC in the US
C Jeldres, S Baillargeon-Gagne, D Liberman, H Isbarn, U Capitanio, SF Shariat, M Sun, G Lughezzani, P Perrotte, F Montorsi, M Graefen, PI Karakiewicz
20090901
2009 Oct 1
Urology
A Population-Based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States
Urology. 2009 Oct 1;74(4):837-841, C Jeldres, S Baillargeon-Gagne, D Liberman, H Isbarn, U Capitanio, SF Shariat, M Sun, G Lughezzani, P Perrotte, F Montorsi, M Graefen, PI Karakiewicz
TAKE-HOME MESSAGE
Abstract
Abstract
Objective: To examine temporal, geographic, socioeconomic, and clinical determinants of cytoreductive nephrectomy (CNT) use in the surveillance, epidemiology, and end results (SEER) database, because CNT is known to improve survival in patients with metastatic renal cell carcinoma (mRCC). Methods: Within the SEER database, we identified 6226 mRCC patients, who were either treated with CNT (n = 2038) or underwent no surgery (n = 4188) between 1989 and 2004. Chi-square and chi-square trend tests,...
